BRIEF-Myriad Genetics launches the endopredict test in U.S for patients with breast cancer
March 13, 2017 at 07:15 AM EDT
* Myriad Genetics launches the endopredict test in the United States for patients with breast cancer Source text for Eikon: Further company coverage: